Totally plc

Totally plc, operating through its various subsidiaries, specializes in providing out-of-hospital healthcare services throughout the United Kingdom and Ireland. The company's operations are divided into three primary segments: Urgent Care, Planned Care, and Insourcing. Within its Planned Care segment, Totally plc offers a spectrum of treatments and advice for musculoskeletal conditions, such as physiotherapy and podiatry for NHS patients. It also extends fitness, occupational health, and ergonomic services to corporate and private clientele, alongside dermatology and referral management solutions. The Urgent Care segment includes direct urgent care provision and clinical health coaching designed to equip patients with the skills to self-manage conditions like chronic obstructive pulmonary disease. Additionally, the company provides hospital insourcing services, develops IT healthcare solutions, and facilitates online health and safety risk assessments. Founded in 1999, Totally plc maintains its headquarters in Derby, United Kingdom.

Totally plc trades as TLY.L on LSE. The company is classified in Healthcare / Medical - Care Facilities and reports in GBP.

The current profile places the business in Medical - Care Facilities. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows £106.68M of revenue and -£3.13M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Totally plc can be compared against peers such as Deltex Medical Group plc, DeepVerge plc, Kanabo Group Plc, LungLife AI, Inc., Oncimmune Holdings plc, Ovoca Bio plc.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of £471,713, beta of -0.01, and return on equity of -9.3%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

TLY.L currently shows total debt of £4.97M and beta of -0.01. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.totallyplc.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.